Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 292

1.

Radiation and chemotherapy for high-risk lower grade gliomas: Choosing between temozolomide and PCV.

McDuff SGR, Dietrich J, Atkins KM, Oh KS, Loeffler JS, Shih HA.

Cancer Med. 2019 Nov 7. doi: 10.1002/cam4.2686. [Epub ahead of print] Review.

2.

Atypical Histopathological Features and the Risk of Treatment Failure in Nonmalignant Meningiomas: A Multi-Institutional Analysis.

Lamba N, Hwang WL, Kim DW, Niemierko A, Marciscano AE, Mehan WA Jr, Benayoun MD, Curry WT, Barker FG 2nd, Martuza RL, Dunn IF, Claus E, Bi WL, Aizer AA, Alexander BM, Oh KS, Loeffler JS, Shih HA.

World Neurosurg. 2019 Oct 9. pii: S1878-8750(19)32617-8. doi: 10.1016/j.wneu.2019.10.002. [Epub ahead of print]

PMID:
31605839
3.

Dynamic Changes in Arteriovenous Malformations (AVMs): Spontaneous Growth and Resolution of AVM-Associated Aneurysms in Two Pediatric Patients.

Koch MJ, Mahal BAV, Hadzipasic M, Fehnel KP, Chapman PH, Loeffler JS, Orbach DB, Smith ER.

Pediatr Neurosurg. 2019;54(6):394-398. doi: 10.1159/000501041. Epub 2019 Oct 9.

PMID:
31597140
4.

Volumetric and actuarial analysis of brain necrosis in proton therapy using a novel mixture cure model.

Niyazi M, Niemierko A, Paganetti H, Söhn M, Schapira E, Goldberg S, Adams J, Kim V, Oh KS, Hwang WL, Lu HM, Belka C, Busse PM, Loeffler JS, Shih HA.

Radiother Oncol. 2019 Sep 25. pii: S0167-8140(19)33092-0. doi: 10.1016/j.radonc.2019.09.008. [Epub ahead of print]

PMID:
31563411
5.

Brachytherapy as an Adjuvant for Recurrent Atypical and Malignant Meningiomas.

Koch MJ, Agarwalla PK, Royce TJ, Shih HA, Oh K, Niemierko A, Mauceri TC, Curry WT, Barker FG, Loeffler JS.

Neurosurgery. 2019 Nov 1;85(5):E910-E916. doi: 10.1093/neuros/nyz115.

PMID:
31329941
6.

Assessing the interactions between radiotherapy and antitumour immunity.

Grassberger C, Ellsworth SG, Wilks MQ, Keane FK, Loeffler JS.

Nat Rev Clin Oncol. 2019 Dec;16(12):729-745. doi: 10.1038/s41571-019-0238-9. Epub 2019 Jun 26. Review.

PMID:
31243334
7.

Long-term outcomes and late adverse effects of a prospective study on proton radiotherapy for patients with low-grade glioma.

Tabrizi S, Yeap BY, Sherman JC, Nachtigall LB, Colvin MK, Dworkin M, Fullerton BC, Daartz J, Royce TJ, Oh KS, Batchelor TT, Curry WT, Loeffler JS, Shih HA.

Radiother Oncol. 2019 Aug;137:95-101. doi: 10.1016/j.radonc.2019.04.027. Epub 2019 May 10.

PMID:
31082632
8.

Patterns of Failure Among Patients With Low-grade Glioma Treated With Proton Radiation Therapy.

Kamran SC, Dworkin M, Niemierko A, Bussiere M, Oh KS, Loeffler JS, Shih HA.

Pract Radiat Oncol. 2019 Jul - Aug;9(4):e356-e361. doi: 10.1016/j.prro.2019.02.002. Epub 2019 Feb 18.

PMID:
30790717
9.

Hypopituitarism After Cranial Irradiation for Meningiomas: A Single-Institution Experience.

Lamba N, Bussiere MR, Niemierko A, Abedi P, Fullerton BC, Loeffler JS, Oh KS, Nachtigall LB, Shih HA.

Pract Radiat Oncol. 2019 May;9(3):e266-e273. doi: 10.1016/j.prro.2019.01.009. Epub 2019 Feb 4.

PMID:
30731274
10.

Performance of a Hospital Pathway for Patients With a New Single Brain Mass.

Arrillaga-Romany I, Curry WT Jr, Jordan JT, Cahill DP, Nahed BV, Martuza RL, Loeffler JS, Järhult SJ, Muzikansky A, Cohen AB, Singhal AB, Goldstein JN, Batchelor TT.

J Oncol Pract. 2019 Mar;15(3):e211-e218. doi: 10.1200/JOP.17.00098. Epub 2019 Jan 25.

PMID:
30681891
11.

Long-term impact of a faculty mentoring program in academic medicine.

Efstathiou JA, Drumm MR, Paly JP, Lawton DM, O'Neill RM, Niemierko A, Leffert LR, Loeffler JS, Shih HA.

PLoS One. 2018 Nov 29;13(11):e0207634. doi: 10.1371/journal.pone.0207634. eCollection 2018.

12.

Increase of pseudoprogression and other treatment related effects in low-grade glioma patients treated with proton radiation and temozolomide.

Dworkin M, Mehan W, Niemierko A, Kamran SC, Lamba N, Dietrich J, Martinez-Lage M, Oh KS, Batchelor TT, Wen PY, Loeffler JS, Shih HA.

J Neurooncol. 2019 Mar;142(1):69-77. doi: 10.1007/s11060-018-03063-1. Epub 2018 Nov 28.

PMID:
30488294
13.

Correction to: Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): A Pituitary Society Statement.

Casanueva FF, Barkan AL, Buchfelder M, Klibanski A, Laws ER, Loeffler JS, Melmed S, Mortini P, Wass J, Giustina A; Pituitary Society, Expert Group on Pituitary Tumors.

Pituitary. 2018 Dec;21(6):663. doi: 10.1007/s11102-018-0912-4.

14.

Proton Stereotactic Radiosurgery for Brain Metastases: A Single-Institution Analysis of 370 Patients.

Atkins KM, Pashtan IM, Bussière MR, Kang KH, Niemierko A, Daly JE, Botticello TM, Hurd MC, Chapman PH, Oh K, Loeffler JS, Shih HA.

Int J Radiat Oncol Biol Phys. 2018 Jul 15;101(4):820-829. doi: 10.1016/j.ijrobp.2018.03.056. Epub 2018 Apr 4.

PMID:
29976494
15.

Safety of combining radiotherapy with immune-checkpoint inhibition.

Hwang WL, Pike LRG, Royce TJ, Mahal BA, Loeffler JS.

Nat Rev Clin Oncol. 2018 Aug;15(8):477-494. doi: 10.1038/s41571-018-0046-7. Review.

PMID:
29872177
16.

"Radiobiology of Proton Therapy": Results of an international expert workshop.

Lühr A, von Neubeck C, Pawelke J, Seidlitz A, Peitzsch C, Bentzen SM, Bortfeld T, Debus J, Deutsch E, Langendijk JA, Loeffler JS, Mohan R, Scholz M, Sørensen BS, Weber DC, Baumann M, Krause M; “Radiobiology of Proton Therapy”.

Radiother Oncol. 2018 Jul;128(1):56-67. doi: 10.1016/j.radonc.2018.05.018. Epub 2018 Jun 1. Review.

PMID:
29861141
17.

The role of proton beam therapy in central neurocytoma: A single-institution experience.

Kang KH, Schapira E, Niemierko A, Martinez-Lage M, Bussière MR, Yock TI, Loeffler JS, Butler WE, Carter BS, Shih HA.

Pract Radiat Oncol. 2018 Sep - Oct;8(5):e305-e311. doi: 10.1016/j.prro.2018.02.005. Epub 2018 Feb 16.

PMID:
29706302
18.

Temozolomide therapy for aggressive functioning pituitary adenomas refractory to surgery and radiation: a case series.

Jordan JT, Miller JJ, Cushing T, Seijo M, Batchelor TT, Arrillaga-Romany IC, Shih HA, Nachtigall LB, Loeffler JS, Dietrich J.

Neurooncol Pract. 2018 Mar;5(1):64-68. doi: 10.1093/nop/npx013. Epub 2017 May 26.

19.

Editorial: Charged Particles in Oncology.

Durante M, Cucinotta FA, Loeffler JS.

Front Oncol. 2017 Dec 8;7:301. doi: 10.3389/fonc.2017.00301. eCollection 2017. No abstract available.

20.

NCCN Guidelines Insights: Central Nervous System Cancers, Version 1.2017.

Nabors LB, Portnow J, Ammirati M, Baehring J, Brem H, Butowski N, Fenstermaker RA, Forsyth P, Hattangadi-Gluth J, Holdhoff M, Howard S, Junck L, Kaley T, Kumthekar P, Loeffler JS, Moots PL, Mrugala MM, Nagpal S, Pandey M, Parney I, Peters K, Puduvalli VK, Ragsdale J, Rockhill J, Rogers L, Rusthoven C, Shonka N, Shrieve DC, Sills AK, Swinnen LJ, Tsien C, Weiss S, Wen PY, Willmarth N, Bergman MA, Engh A.

J Natl Compr Canc Netw. 2017 Nov;15(11):1331-1345. doi: 10.6004/jnccn.2017.0166.

PMID:
29118226
21.

The impact of different stereotactic radiation therapy regimens for brain metastases on local control and toxicity.

Jimenez RB, Alexander BM, Mahadevan A, Niemierko A, Rajakesari S, Arvold ND, Floyd SR, Oh KS, Loeffler JS, Shih HA.

Adv Radiat Oncol. 2017 Jun 6;2(3):391-397. doi: 10.1016/j.adro.2017.05.008. eCollection 2017 Jul-Sep.

22.

MicroRNA-378 enhances radiation response in ectopic and orthotopic implantation models of glioblastoma.

Li W, Liu Y, Yang W, Han X, Li S, Liu H, Gerweck LE, Fukumura D, Loeffler JS, Yang BB, Jain RK, Huang P.

J Neurooncol. 2018 Jan;136(1):63-71. doi: 10.1007/s11060-017-2646-y. Epub 2017 Oct 28.

23.

Three ways to make proton therapy affordable.

Bortfeld TR, Loeffler JS.

Nature. 2017 Sep 25;549(7673):451-453. doi: 10.1038/549451a. No abstract available.

PMID:
28959981
24.

Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): A Pituitary Society Statement.

Casanueva FF, Barkan AL, Buchfelder M, Klibanski A, Laws ER, Loeffler JS, Melmed S, Mortini P, Wass J, Giustina A; Pituitary Society, Expert Group on Pituitary Tumors.

Pituitary. 2017 Oct;20(5):489-498. doi: 10.1007/s11102-017-0838-2. Erratum in: Pituitary. 2018 Sep 20;:.

25.

Prospective, Randomized Study of Radiation Dose Escalation With Combined Proton-Photon Therapy for Benign Meningiomas.

Sanford NN, Yeap BY, Larvie M, Daartz J, Munzenrider JE, Liebsch NJ, Fullerton B, Pan E, Loeffler JS, Shih HA.

Int J Radiat Oncol Biol Phys. 2017 Nov 15;99(4):787-796. doi: 10.1016/j.ijrobp.2017.07.008. Epub 2017 Jul 12.

26.

Histopathological prognostic factors of recurrence following definitive therapy for atypical and malignant meningiomas.

Kim D, Niemierko A, Hwang WL, Stemmer-Rachamimov AO, Curry WT, Barker FG, Martuza RL, Oh KS, Loeffler JS, Shih HA.

J Neurosurg. 2018 Apr;128(4):1123-1132. doi: 10.3171/2016.11.JNS16913. Epub 2017 Jun 16.

PMID:
28621619
27.

Charged-particle therapy in cancer: clinical uses and future perspectives.

Durante M, Orecchia R, Loeffler JS.

Nat Rev Clin Oncol. 2017 Aug;14(8):483-495. doi: 10.1038/nrclinonc.2017.30. Epub 2017 Mar 14. Review.

PMID:
28290489
28.

Spatiotemporal Fractionation Schemes for Irradiating Large Cerebral Arteriovenous Malformations.

Unkelbach J, Bussière MR, Chapman PH, Loeffler JS, Shih HA.

Int J Radiat Oncol Biol Phys. 2016 Jul 1;95(3):1067-1074. doi: 10.1016/j.ijrobp.2016.02.001. Epub 2016 Feb 6.

29.

De novo development of a cerebral arteriovenous malformation following radiation therapy: Case report and an update to classical arteriovenous malformation nomenclature.

Koch MJ, Agarwalla PK, Stapleton CJ, Ogilvy CS, Loeffler JS.

J Clin Neurosci. 2016 Jun;28:162-7. doi: 10.1016/j.jocn.2015.11.021. Epub 2016 Feb 6.

PMID:
26860850
30.

Imaging and extent of surgical resection predict risk of meningioma recurrence better than WHO histopathological grade.

Hwang WL, Marciscano AE, Niemierko A, Kim DW, Stemmer-Rachamimov AO, Curry WT, Barker FG 2nd, Martuza RL, Loeffler JS, Oh KS, Shih HA, Larvie M.

Neuro Oncol. 2016 Jun;18(6):863-72. doi: 10.1093/neuonc/nov285. Epub 2015 Nov 22.

31.

Neurocognitive effects of proton radiation therapy in adults with low-grade glioma.

Sherman JC, Colvin MK, Mancuso SM, Batchelor TT, Oh KS, Loeffler JS, Yeap BY, Shih HA.

J Neurooncol. 2016 Jan;126(1):157-164. doi: 10.1007/s11060-015-1952-5.

PMID:
26498439
32.

BRAF alteration status and the histone H3F3A gene K27M mutation segregate spinal cord astrocytoma histology.

Shankar GM, Lelic N, Gill CM, Thorner AR, Van Hummelen P, Wisoff JH, Loeffler JS, Brastianos PK, Shin JH, Borges LF, Butler WE, Zagzag D, Brody RI, Duhaime AC, Taylor MD, Hawkins CE, Louis DN, Cahill DP, Curry WT, Meyerson M.

Acta Neuropathol. 2016 Jan;131(1):147-50. No abstract available.

33.

Central Nervous System Cancers, Version 1.2015.

Nabors LB, Portnow J, Ammirati M, Baehring J, Brem H, Brown P, Butowski N, Chamberlain MC, Fenstermaker RA, Friedman A, Gilbert MR, Hattangadi-Gluth J, Holdhoff M, Junck L, Kaley T, Lawson R, Loeffler JS, Lovely MP, Moots PL, Mrugala MM, Newton HB, Parney I, Raizer JJ, Recht L, Shonka N, Shrieve DC, Sills AK Jr, Swinnen LJ, Tran D, Tran N, Vrionis FD, Weiss S, Wen PY, McMillian N, Engh AM.

J Natl Compr Canc Netw. 2015 Oct;13(10):1191-202.

PMID:
26483059
34.

Benign meningiomas (WHO Grade I) with atypical histological features: correlation of histopathological features with clinical outcomes.

Marciscano AE, Stemmer-Rachamimov AO, Niemierko A, Larvie M, Curry WT, Barker FG 2nd, Martuza RL, McGuone D, Oh KS, Loeffler JS, Shih HA.

J Neurosurg. 2016 Jan;124(1):106-14. doi: 10.3171/2015.1.JNS142228. Epub 2015 Aug 14.

PMID:
26274991
35.

Brachytherapy in the treatment of recurrent aggressive falcine meningiomas.

Abou Al-Shaar H, Almefty KK, Abolfotoh M, Arvold ND, Devlin PM, Reardon DA, Loeffler JS, Al-Mefty O.

J Neurooncol. 2015 Sep;124(3):515-22. doi: 10.1007/s11060-015-1873-3. Epub 2015 Aug 8.

PMID:
26253325
36.

The Changing Landscape of Whole-Brain Radiation Therapy.

Oh KS, Loeffler JS.

JAMA Oncol. 2015 Jul;1(4):464-5. doi: 10.1001/jamaoncol.2015.1144. No abstract available.

PMID:
26181255
37.

Remote acute demyelination after focal proton radiation therapy for optic nerve meningioma.

Redjal N, Agarwalla PK, Dietrich J, Dinevski N, Stemmer-Rachamimov A, Nahed BV, Loeffler JS.

J Clin Neurosci. 2015 Aug;22(8):1367-9. doi: 10.1016/j.jocn.2015.02.017. Epub 2015 Apr 27.

PMID:
25937571
38.

Repeat radiosurgery for cerebral arteriovenous malformations.

Awad AJ, Walcott BP, Stapleton CJ, Ding D, Leed CC, Loeffler JS.

J Clin Neurosci. 2015 Jun;22(6):945-950. doi: 10.1016/j.jocn.2015.01.015. Epub 2015 Apr 23. Review.

39.

Lessons from anti-vascular endothelial growth factor and anti-vascular endothelial growth factor receptor trials in patients with glioblastoma.

Lu-Emerson C, Duda DG, Emblem KE, Taylor JW, Gerstner ER, Loeffler JS, Batchelor TT, Jain RK.

J Clin Oncol. 2015 Apr 1;33(10):1197-213. doi: 10.1200/JCO.2014.55.9575. Epub 2015 Feb 23.

40.

Proton therapy for low-grade gliomas: Results from a prospective trial.

Shih HA, Sherman JC, Nachtigall LB, Colvin MK, Fullerton BC, Daartz J, Winrich BK, Batchelor TT, Thornton LT, Mancuso SM, Saums MK, Oh KS, Curry WT, Loeffler JS, Yeap BY.

Cancer. 2015 May 15;121(10):1712-9. doi: 10.1002/cncr.29237. Epub 2015 Jan 13.

41.

Central nervous system cancers, version 2.2014. Featured updates to the NCCN Guidelines.

Nabors LB, Portnow J, Ammirati M, Brem H, Brown P, Butowski N, Chamberlain MC, DeAngelis LM, Fenstermaker RA, Friedman A, Gilbert MR, Hattangadi-Gluth J, Hesser D, Holdhoff M, Junck L, Lawson R, Loeffler JS, Moots PL, Mrugala MM, Newton HB, Raizer JJ, Recht L, Shonka N, Shrieve DC, Sills AK Jr, Swinnen LJ, Tran D, Tran N, Vrionis FD, Wen PY, McMillian NR, Ho M.

J Natl Compr Canc Netw. 2014 Nov;12(11):1517-23.

42.

Radiation therapy in the management of pituitary adenomas.

Pashtan I, Oh KS, Loeffler JS.

Handb Clin Neurol. 2014;124:317-24. doi: 10.1016/B978-0-444-59602-4.00021-6. Review.

PMID:
25248596
43.

Outcomes of proton therapy for patients with functional pituitary adenomas.

Wattson DA, Tanguturi SK, Spiegel DY, Niemierko A, Biller BM, Nachtigall LB, Bussière MR, Swearingen B, Chapman PH, Loeffler JS, Shih HA.

Int J Radiat Oncol Biol Phys. 2014 Nov 1;90(3):532-9. doi: 10.1016/j.ijrobp.2014.06.068. Epub 2014 Sep 3.

PMID:
25194666
44.

Brain tumor cells in circulation are enriched for mesenchymal gene expression.

Sullivan JP, Nahed BV, Madden MW, Oliveira SM, Springer S, Bhere D, Chi AS, Wakimoto H, Rothenberg SM, Sequist LV, Kapur R, Shah K, Iafrate AJ, Curry WT, Loeffler JS, Batchelor TT, Louis DN, Toner M, Maheswaran S, Haber DA.

Cancer Discov. 2014 Nov;4(11):1299-309. doi: 10.1158/2159-8290.CD-14-0471. Epub 2014 Aug 19.

45.

Cranial stereotactic radiosurgery: current status of the initial paradigm shifter.

Sheehan JP, Yen CP, Lee CC, Loeffler JS.

J Clin Oncol. 2014 Sep 10;32(26):2836-46. doi: 10.1200/JCO.2013.53.7365. Epub 2014 Aug 11. Review.

46.

Significance of targeted therapy and genetic alterations in EGFR, ALK, or KRAS on survival in patients with non-small cell lung cancer treated with radiotherapy for brain metastases.

Mak KS, Gainor JF, Niemierko A, Oh KS, Willers H, Choi NC, Loeffler JS, Sequist LV, Shaw AT, Shih HA.

Neuro Oncol. 2015 Feb;17(2):296-302. doi: 10.1093/neuonc/nou146. Epub 2014 Jul 22.

47.

Green eggs and ham: Strategies to address the growing phenomenon of selling a medical school's name.

Falit BP, Halperin EC, Loeffler JS.

Acad Med. 2014 Dec;89(12):1614-6. doi: 10.1097/ACM.0000000000000397.

48.

Single-fraction proton beam stereotactic radiosurgery for cerebral arteriovenous malformations.

Hattangadi-Gluth JA, Chapman PH, Kim D, Niemierko A, Bussière MR, Stringham A, Daartz J, Ogilvy C, Loeffler JS, Shih HA.

Int J Radiat Oncol Biol Phys. 2014 Jun 1;89(2):338-46. doi: 10.1016/j.ijrobp.2014.02.030. Epub 2014 Apr 11.

PMID:
24726288
49.

Pretreatment growth rate predicts radiation response in vestibular schwannomas.

Niu NN, Niemierko A, Larvie M, Curtin H, Loeffler JS, McKenna MJ, Shih HA.

Int J Radiat Oncol Biol Phys. 2014 May 1;89(1):113-9. doi: 10.1016/j.ijrobp.2014.01.038.

PMID:
24725695
50.

Low-grade gliomas.

Forst DA, Nahed BV, Loeffler JS, Batchelor TT.

Oncologist. 2014 Apr;19(4):403-13. doi: 10.1634/theoncologist.2013-0345. Epub 2014 Mar 24. Review.

Supplemental Content

Loading ...
Support Center